RA-9
RA-9 is a potent and selective proteasome-associated deubiquitinating enzymes (DUBs) inhibitor with favorable toxicity profile and anticancer activity. RA-9 blocks ubiquitin-dependent protein degradation without impacting 20S proteasome proteolytic activity. RA-9 selectively induces onset of apoptosis in ovarian cancer cell lines and primary cultures derived from donors. RA-9 induces endoplasmic reticulum (ER) -stress responses in ovarian cancer cells[1].
Product Specifications
CAS Number
919091-63-7
UNSPSC
12352005
Hazard Statement
H302
Target
Apoptosis; Deubiquitinase
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ra-9.html
Concentration
10mM
Purity
98.57
Solubility
DMSO : 4.17 mg/mL (ultrasonic; warming; heat to 80°C)
Smiles
O=C1/C(CNC/C1=C\C2=CC=C([N+]([O-])=O)C=C2)=C/C3=CC=C([N+]([O-])=O)C=C3
Molecular Formula
C19H15N3O5
Molecular Weight
365.34
Precautions
H302
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Factor H (CFH) (NM_001014975) Human Over-expression Lysate
![CD40 Mouse Monoclonal Antibody [Clone ID: OTI13B4]](https://cdn.genprice.uk/products/937/68dd18bb061270361e908edd/imageurl/cf813203.webp)
